Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 26 2024

Full Issue

Covid Vaccines Violated Patent Rights, GlaxoSmithKline Contends In Lawsuit

Meanwhile, Acuitas Therapeutics and CureVac reach an agreement in another patent lawsuit regarding technology used in mRNA-based Covid shots. Also, Maine's high court lets stand a mandate that EMS workers must be vaccinated against Covid.

Reuters: GlaxoSmithKline Sues Pfizer And BioNTech Over Covid-19 Vaccine Technology 

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic. (Brittain, 4/25)

Reuters: Acuitas, CureVac Settle Lawsuit Over COVID-19 Vaccine Patent Rights 

Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia federal court. Acuitas sued CureVac last year in U.S. District Court for the Eastern District of Virginia, claiming its scientists should have been named as co-inventors of CureVac patents covering technology used in messenger RNA (mRNA)-based shots. CureVac told the court on Thursday that they had settled their dispute and will ask to dismiss the case. (Brittain, 4/25)

WGME: Maine Supreme Court Upholds EMS Authority For Covid Vaccine Mandate

EMS workers in Maine will still have to get Covid vaccine shots, with the Maine Supreme Court upholding that rule this week. A man filed a complaint in December 2022, claiming Maine EMS didn't have the authority to issue vaccination requirements. A court tossed out the lawsuit last year. The man appealed but on Wednesday, the Maine Supreme Court upheld that court, ruling Maine EMS does have the authority to require vaccinations for its first responders. (4/25)

More covid news —

CIDRAP: COVID May Have Eroded Doctors' Belief That They Are Obligated To Treat Infectious Patients 

A systematic review posted in Clinical Infectious Diseases reveals that, amid the COVID-19 pandemic, many physicians felt less ethically obligated to provide care to infectious-disease patients if they fear contracting the disease. A Duke University–led team reviewed 155 published studies exploring treatment obligation and refusal, HIV/AIDS, COVID-19, and pandemics up to October 25, 2022. The included studies examined ethical treatment obligations for patients with HIV/AIDS (72.2%), severe acute respiratory syndrome (SARS; 10.2%), COVID-19 (10.2%), Ebola (7.0%), and flu (7.0%). (Van Beusekom, 4/25)

CIDRAP: Impaired Sense Of Smell Still Common 1 Year After COVID-19

Sense of smell—but not taste—was still impaired in some COVID patients at 1 year, according to a new study in JAMA Network Open. The US-based cross-sectional study compared 340 people with and 434 without prior COVID-19, recruited from February 2020 to August 2023 from the social media website Reddit. (Soucheray, 4/25)

On the spread of mpox —

USA Today: Mpox Outbreak Reported In Cuyahoga County, Ohio: Symptoms, Risks, More

Health officials in Ohio have announced an mpox outbreak after 11 cases have been reported in recent months. Since February, there have been 11 reported cases within Cuyahoga County, which encompasses Cleveland and surrounding suburbs. ... Joyous Van Meter, disease and emergency preparedness supervisor, at Cuyahoga County Board of Health told USA TODAY all of the reported cases are men. (Forbes, 4/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF